Armistice Capital »

Envista Hldgs Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Envista Hldgs Corp (NVST) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Envista Hldgs Corp

Tip: Access up to 7 years of quarterly data

All positions including Envista Hldgs Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Envista Hldgs Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.7M 264k 25.37
2019-12-31 $25M 848k 29.64

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Envista Hldgs Corp

BlackRock
Vanguard Group
Ariel Investments
Dimensional Fund Advisors
Morgan Stanley
Vanguard Portfolio Management
Vanguard Capital Management
Franklin Resources
Victory Capital Management
Gates Capital Management
State Street Corporation
Alliancebernstein
American Century Companies
Citadel Advisors
Hanna Zanoni

View all funds holding Envista Hldgs Corp